TY  - JOUR
T1  - GRoups propose plan to accredit controversial stem cell therapy clinics
AU  - Kuehn BM
Y1  - 2012/08/08
N1  - 10.1001/jama.2012.7959
JO  - JAMA
SP  - 553
EP  - 555
VL  - 308
IS  - 6
N2  - 
The proliferation of clinics offering stem cell treatments for dozens of conditions, ranging from autism to chronic obstructive pulmonary disease, has raised concerns among stem cell researchers, ethicists, and the US Food and Drug Administration (FDA). Most such clinics operate outside the United States, so they do not need FDA permission to conduct clinical trials involving stem cell treatments or to market stem cell treatments to patients, but many of the clinics recruit patients from the United States.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.7959
UR  - http://dx.doi.org/10.1001/jama.2012.7959
ER  -